Technology News and Research

RSS

Taconic To Promote And Sell Medicyte Hepatocyte Products

...

4 Sep 2013

Study identifies new tool to accurately analyze mtDNA deletions associated with diseases, aging

A study published today in Aging Cell identifies a new tool to accurately analyze extremely rare mitochondrial DNA deletions associated with a range of diseases and disorders as well as aging. This approach, which relies on Droplet Digital PCR (ddPCR-) technology, will help researchers explore mtDNA deletions as potential disease biomarkers.

4 Sep 2013

Free reference and lifestyle tool now available for people affected by paralysis

For the first time, individuals living with paralysis and their caregivers can access the comprehensive Paralysis Resource Guide digitally on their smartphone, Nook, iPad or Kindle. The third edition of this vital resource, compiled and distributed by the Christopher & Dana Reeve Foundation Paralysis Resource Center, is a free reference and lifestyle tool for people affected by paralysis.

4 Sep 2013

Research finding provides blueprint for understanding how the brain communicates with itself

During a normal conversation, your brain is constantly adjusting the volume to soften the sound of your own voice and boost the voices of others in the room.

4 Sep 2013

65 metabolites in urine simultaneously measured by clinical IEM-by-NMR screening study in Turkey

At the 12th International Congress of Inborn Errors of Metabolism (www.iciem2013.com), Bruker announces another milestone in the cost-effective use of NMR (nuclear magnetic resonance) spectroscopy screening as a clinical research tool for metabolic screening and small molecule in vitro diagnostics (IVD) research and validation.

4 Sep 2013

Radiologists train military physicians to remove foreign bodies with ultrasound-guided techniques

William E. Shiels II, DO, chief of the Nationwide Children's Hospital Department of Radiology and president of Children's Radiological Institute, Inc., is leading a team of radiologists for the training of military physicians to remove shrapnel foreign bodies from warfighters with ultrasound-guided techniques that he originally developed, with subsequent improvements made by the full team of Nationwide Children's Hospital interventional radiologists.

4 Sep 2013

RVX-208 drug fails to increase good cholesterol levels in ASSURE trial

Patients with coronary artery disease and low levels of "good cholesterol - or high-density lipoprotein - who were treated with a drug designed to increase HDL levels and reduce coronary plaque build-up, experienced no better results than those treated with placebo, according to research conducted by the Cleveland Clinic Coordinating Center for Clinical Research.

4 Sep 2013

New recombinant antibody can recognize MSCs in umbilical cord blood

A new recombinant antibody can detect and isolate mesenchymal stem cells (MSCs), a nonembryonic source of stem cells with promising applications in tissue engineering, blood stem cell transplantation, and treatments for immune-mediated disorders.

4 Sep 2013

Study shows surgical robot technology reports misleading picture of safety

Despite widespread adoption by hospitals of surgical robot technology over the past decade, a "slapdash" system of reporting complications paints a , according to Johns Hopkins researchers.

4 Sep 2013

UCLA researchers receives $13M Early Translational grants to advance innovative discoveries using stem cells

Four researchers from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have received Early Translational Research Awards totaling approximately $13 million from the California Institute for Regenerative Medicine, the state's stem cell agency. The UCLA researchers received four of the 12 total awards; no other institution received more than one.

4 Sep 2013

AQUARIUS trial data shows Aliskiren reduced incidents of death, stroke, heart attack

Patients with clogged and hardened arteries who already have their blood pressure under control may benefit from an additional blood pressure-lowering medication, according to research from the Cleveland Clinic Coordinating Center for Clinical Research (C5Research).

4 Sep 2013

Cangene Signs Up To $77M Contract Extension With CDC

...

3 Sep 2013

Enanta Gets Additional $9.2M Toward Biodefense Antibiotic Development

...

3 Sep 2013

Baxter, Coherus Ink Biosimilar Collaboration Worth Up To $246M

...

3 Sep 2013

Cangene Inks Up To $77M Contract Extension With CDC

...

3 Sep 2013

Implantation rate of CIEDs continues to rise in most European countries

Infections cause a lower proportion of lead extractions than expected, according to preliminary results from the ELECTRa Registry presented at ESC Congress 2013 today by Dr Maria Grazia Bongiorni from Italy.

3 Sep 2013

VolitionRx-led consortium receives grant to develop novel NuQ biomarkers for immune response

...

3 Sep 2013

BME introduces new, improved Speed Continuous Active Compression System

BME, Inc., the privately held U.S. Leader in Nitinol Technology Implants and Instruments known under the brands of: Speed™ (fully-disposable continuous active compression system), HammerLock® (intramedullary hammertoe correction system), OSStaple™ (Nitinol continuous active compression system) and OSSforce™ (heat-activating implant controller), has announced today its' introduction of a new, improved Speed™ Continuous Active Compression System.

3 Sep 2013

Sanomedics completes acquisition of Prime Time Medical

Sanomedics International Holdings, Inc., a medical technology holding company that focuses on game-changing products, services and ideas, today announced that it has completed the previously announced acquisition of Prime Time Medical, Inc., of Largo, Florida for a total purchase price of $3,100,000, effective August 30, 2013.

3 Sep 2013

Sigma Life Science signs license agreement with Horizon Discovery for CompoZr ZFN technology

Sigma-Aldrich Corporation today announced that Sigma Life Science, its innovative biological products and services business, has entered a non-exclusive license agreement with Horizon Discovery for use of Sigma's CompoZr Zinc Finger Nuclease technology.

3 Sep 2013

Technology News and Research

Taconic To Promote And Sell Medicyte Hepatocyte Products

Study identifies new tool to accurately analyze mtDNA deletions associated with diseases, aging

Free reference and lifestyle tool now available for people affected by paralysis

Research finding provides blueprint for understanding how the brain communicates with itself

65 metabolites in urine simultaneously measured by clinical IEM-by-NMR screening study in Turkey

Radiologists train military physicians to remove foreign bodies with ultrasound-guided techniques

RVX-208 drug fails to increase good cholesterol levels in ASSURE trial

New recombinant antibody can recognize MSCs in umbilical cord blood

Study shows surgical robot technology reports misleading picture of safety

UCLA researchers receives $13M Early Translational grants to advance innovative discoveries using stem cells

AQUARIUS trial data shows Aliskiren reduced incidents of death, stroke, heart attack

Cangene Signs Up To $77M Contract Extension With CDC

Enanta Gets Additional $9.2M Toward Biodefense Antibiotic Development

Baxter, Coherus Ink Biosimilar Collaboration Worth Up To $246M

Cangene Inks Up To $77M Contract Extension With CDC

Implantation rate of CIEDs continues to rise in most European countries

VolitionRx-led consortium receives grant to develop novel NuQ biomarkers for immune response

BME introduces new, improved Speed Continuous Active Compression System

Sanomedics completes acquisition of Prime Time Medical

Sigma Life Science signs license agreement with Horizon Discovery for CompoZr ZFN technology

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News